LIMNLiminatus Pharma, Inc. · NASDAQ Global Market · $3.88 · $5.21M mkt cap
Assessed Aug 21, 2026 · Reverse split
Is the float you're seeing correct?
1.00M
Estimated float

Post-split shares outstanding (67,160,362 / 50) less affiliate/insider holdings per DEF 14A record date 2026-07-02 (officers+directors group plus non-overlapping Ewon block) less non-affiliate unregistered InnocsAI merger shares.

Understated 28%
782.7K
Reported float

Data-service feed, fetched today. The number TradingView and most screeners show.

Your screener is showing a float that no longer exists. Trade off 1.00M shares.

Dilution risk8/10HIGH
CONFIDENCE: MEDIUM

The float your screener shows is understated 28%: 782.7K reported, 1.00M actual. 2 convertible notes can add another 3,241% of the float.

  • Preferred stock conversion overhang. 158,881.1271 shares of Series A Non-Voting Convertible Preferred, issued 2026-07-02 as InnocsAI merger consideration, convert at a fixed 10,000:1 pre-split ratio (200:1 after the 1-for-50 split) into…

  • Rapid share count growth. Deterministic XBRL data shows shares outstanding grew 49.7% in a single quarter — from 44,877,633 on 2026-05-14 to 67,160,362 on 2026-08-14 (+22,282,729 shares) — and 148% over twelve months from 27,…

  • Reverse split history. A 1-for-50 reverse split became effective 2026-08-21, compressing 67,160,362 shares to approximately 1,343,208 and leaving 500,000,000 shares authorized — restoring roughly 372x headroom over the pos…

From today's float to the ceiling

shares
1.00M
Estimated float
tradeable today
+0 can sell now
1.00M
Effective supply
float plus what sells on notice
+32.89M if floors are cut and warrants exercise
33.90M
Fully diluted
ceiling

Where the shares come from

each subtotal is a rung on the ladder above

Tradeable today
1.00M
Can sell now
Warrants in the money
None of the outstanding warrants are exercisable at this price.
+0
Effective supply
1.00M
Converts only if floors are cut
Notes with no conversion price set
Sized in dollars until a price or floor is set; not counted in the ceiling.
$1.94M
Preferred stock, as converted
Common equivalent at the stated conversion ratio.
+31.78M
Above the current price
Warrants out of the money
Struck above the current tape; supply only if the stock rises.
+738.7K
Other, per engine ceiling
Included in the engine's fully-diluted count but not itemised in the filings we parsed.
+378.7K
Fully diluted
33.90M

Not counted anywhere: ATM and shelf capacity. Convertible share counts use stated conversion prices.

See the full breakdown

Red flags, financing counterparties, the deal timeline, and every SEC filing — free with an account.

Sign in to continue

The facts

Price
$3.88
Market cap
$5.21M
Shares outstanding
1.34M
Reported float
782.7K
Avg volume
20.8K
Reverse splits
1 · latest 1-for-50 · Aug 21, 2026
Going concern
Yes · 2 quarters runway
Quarterly burn
$1.50M

Market data as of Oct 8, 2026

Key dates

  • Dec 3, 2026 · Expiration of the six-month Variable Rate Transaction prohibition from the June 2026 inducement — after which floating-price convertibles and equity lines beco…
  • Dec 31, 2026 · Outside termination date referenced in the InnocsAI merger framework
  • Jan 2, 2027 · Rule 144 six-month holding period matures on the 11,188,729 pre-split InnocsAI merger shares issued 2026-07-02
LIMN Float & Dilution Analysis | ShareStructure.io